Den samlede Cmin af carbamazepin og dets aktive metabolits Cmin er forøget med 23%, hvilket ikke forventes at have kliniske konsekvenser.
The total Cmin of carbamazepine and its active metabolite Cmin is increased by 23% which is not expected to have clinical consequences.